Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Camrelizumab”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04649476
What this trial is testing

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma
Hospital of Stomatology, Wuhan University 68
Testing effectiveness (Phase 2)Temporarily pausedNCT05101616
What this trial is testing

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shanghai Minimally Invasive Surgery Center 100
Testing effectiveness (Phase 2)UnknownNCT05670925
What this trial is testing

A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.

Who this might be right for
Triple-Negative Breast Cancer
Fudan University 46
Testing effectiveness (Phase 2)UnknownNCT04866862
What this trial is testing

Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First Affiliated Hospital with Nanjing Medical University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05043688
What this trial is testing

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li 426
Not applicableWithdrawnNCT04420130
What this trial is testing

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

Who this might be right for
Pancreatic CancerLiver Metastasis
Yanqiao Zhang
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)UnknownNCT04547088
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 27
Testing effectiveness (Phase 2)UnknownNCT06170697
What this trial is testing

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 46
Testing effectiveness (Phase 2)UnknownNCT05184946
What this trial is testing

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
The Second Affiliated Hospital of Shandong First Medical University 72
Large-scale testing (Phase 3)Looking for participantsNCT06438627
What this trial is testing

Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial

Who this might be right for
Nasopharyngeal Carcinoma
XIANG YANQUN 164
Large-scale testing (Phase 3)Looking for participantsNCT06361888
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Hutchmed 502
Testing effectiveness (Phase 2)UnknownNCT04390945
What this trial is testing

Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 62
Testing effectiveness (Phase 2)UnknownNCT03912857
What this trial is testing

Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT04303741
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT04481763
What this trial is testing

The Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

Who this might be right for
Triple-Negative Breast Cancer
Jiangxi Provincial Cancer Hospital 20
Not applicableUnknownNCT04507750
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Who this might be right for
Immune Checkpoint Inhibition
Qianfoshan Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04952571
What this trial is testing

Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)

Who this might be right for
Recurrent Glioblastoma
Beijing Sanbo Brain Hospital 3
Testing effectiveness (Phase 2)UnknownNCT05322499
What this trial is testing

Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Stage IV Esophagus Squamous Cell Carcinoma
Zhejiang Cancer Hospital 80
Testing effectiveness (Phase 2)UnknownNCT05085626
What this trial is testing

Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer

Who this might be right for
Advanced HER2 Negative Breast CarcinomaHRD+Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation